Dr. Brian DeRubertis
Claim this profileNew York Presbyterian Hospital/Cornell University
Studies Critical Limb Ischemia
Studies Peripheral Arterial Disease
5 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Brian DeRubertis is currently running
LimFlow Stent Graft System
for Critical Limb Ischemia
A prospective, single-arm, multi-center study designed to gather additional information on the LimFlow System.
Recruiting1 award N/A10 criteria
Esprit BTK System
for Critical Limb Ischemia
The Esprit BTK PAS is a prospective, single-arm, multi-center observational study to assess the continued safety and effectiveness of the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System under commercial use, in patients with diseased infrapopliteal lesions causing CLTI (Chronic Limb-Threatening Ischemia) in a real-world setting. The clinical investigation will be conducted at up to 50 sites in the United States (US) and additional sites may be added outside of the US (OUS). Approximately 200 patients with a minimum of 50% of patients in the US will be registered in the clinical investigation.
Recruiting1 award N/A4 criteria
More about Brian DeRubertis
Clinical Trial Related3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Brian DeRubertis has experience with
- Esprit BTK System
- Esprit BTK Device
- Percutaneous Transluminal Angioplasty (PTA) Device
- JETi Peripheral Thrombectomy System
- JETi Thrombectomy System
- LimFlow Stent Graft System
Breakdown of trials Brian DeRubertis has run
Critical Limb Ischemia
Peripheral Arterial Disease
Peripheral Vascular Disease
Deep Vein Thrombosis
Intrapericardial Thrombosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brian DeRubertis specialize in?
Brian DeRubertis focuses on Critical Limb Ischemia and Peripheral Arterial Disease. In particular, much of their work with Critical Limb Ischemia has involved treating patients, or patients who are undergoing treatment.
Is Brian DeRubertis currently recruiting for clinical trials?
Yes, Brian DeRubertis is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Brian DeRubertis has studied deeply?
Yes, Brian DeRubertis has studied treatments such as Esprit BTK System, Esprit BTK Device, Percutaneous Transluminal Angioplasty (PTA) Device.
What is the best way to schedule an appointment with Brian DeRubertis?
Apply for one of the trials that Brian DeRubertis is conducting.
What is the office address of Brian DeRubertis?
The office of Brian DeRubertis is located at: New York Presbyterian Hospital/Cornell University, New York, New York 10065 United States. This is the address for their practice at the New York Presbyterian Hospital/Cornell University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.